Escoffre Jean-Michel, Debin Arnaud, Reynes Jean-Paul, Drocourt Daniel, Tiraby Gérard, Hellaudais Laëtitia, Teissie Justin, Golzio Muriel
IPBS Universite P Sabatier/CNRS, UMR 5089, 205 route de Narbonne, 31077 Toulouse, France.
Technol Cancer Res Treat. 2008 Apr;7(2):109-16. doi: 10.1177/153303460800700203.
RNA interference appears as a promising tool for therapeutic gene silencing. A key limit is the delivery of the siRNA. A safe approach is to use a physical method such as in vivo electropulsation with contact electrodes. Getting a long lived silencing can be better approached by using the in situ expression of shRNA. This is presently obtained by using co-electrotransfer of specific plasmids coding for expression and silencing of a fluorescent protein. Using a non invasive fluorescence imaging assay, electrodelivery in mouse muscles is observed to induce complete silencing over more than two months in a specific way. The proper choices of the plasmids (sequence and relative amounts) and of the electric pulsing conditions appear as key parameters in the successful silencing.